# Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.

> **NCT04465409** · NA · ACTIVE_NOT_RECRUITING · sponsor: **LinkoCare Life Sciences AB** · enrollment: 110 (actual)

## Conditions studied

- Presbyopia

## Interventions

- **DEVICE:** Intrastromal implantation of CorVision bioengineered corneal inlay for correction of presbyopia.

## Key facts

- **NCT ID:** NCT04465409
- **Lead sponsor:** LinkoCare Life Sciences AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-03-25
- **Primary completion:** 2022-09-25
- **Final completion:** 2026-06-30
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04465409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04465409, "Evaluation of Safety and Efficacy of Intrastromal Implantation of CorVision® Bioengineered Corneal Inlay for Correction of Presbyopia.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04465409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*